Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by davgroon Sep 09, 2022 3:34pm
136 Views
Post# 34953021

RE:Level ll

RE:Level ll
Duster340 wrote: showing only 200 shares bought, and 11,000 sold  =  total 11.20K

WRONG clearly more buying than selling stock up a penny, i  purchased 2,500 30 minutes ago never registered

Yo Dumpster, you truly know nothing about trading.  Level II only shows you the "order book" for stocks, including the best bid and ask prices by various market makers and other market participants. It does not show you bought and sold trades that have already taken place.

Secondly if you only rely on Stockhouse trade information you are not getting the full market picture as it only shows you trades from the major exchanges and not supplementary exchanges like Alpha, Omega, Pure, CXD or TriAct.  That is why you are not seeing the true volume for the stock.

Your piddly purchase of 2500 shares ot ATE did register but you can't see it because it was transacted on the Alpha exchange (see below).  I wouldn't expect a penny flipping troll like you to truly understand the nuances of stock trading.

14:28:21 A 0.63 0.01 2,500 124 Questrade 79 CIBC K
  

<< Previous
Bullboard Posts
Next >>